Considering the heterogeneity between molecular subtypes defined by specific oxidative stress genes, we identified the DEGs between the two molecular subtypes and deduced a risk assessment system composing of ZYX, GJA5, GAL, GRAMD1B, and CKMT2 for the prognosis of osteosarcoma. The gene discussed is GRAMD1B; the disease is osteosarcoma.